KIND TO BIOME, a company that provides substantiation of microbiome friendly claims in the cosmetic industry, has performed a ...

LGND READ THE FULL LGND RESEARCH REPORT Ligand Pharmaceuticals, Inc. (NASDAQ:LGND) announced that it had identified a suitor to take its subsidiary Pelthos Therapeutics public in an April 17th press ...

The Food and Drug Administration published a notice from Amneal Pharmaceutical that said the company is recalling two lots of ...

Symptoms of a food allergy can include skin issues such as hives and rashes or gastrointestinal problems such as vomiting, diarrhea and stomach cramps.

A Class II recall is the second riskiest of the FDA’s recall classifications and indicates that consumption of the recalled product “may cause temporary or medically reversible adverse health ...

A voluntary recall has been issued for certain batches of a widely sold apple juice brand, according to an alert from the US ...

The FDA is being called out after years of stalled progress and missed deadlines on banning formaldehyde in hair-straightening products. A group of environmental and public health organizations ...

"Currently, there is no FDA-approved topical formulation of finasteride," it continued. "Compounded topical finasteride products do not have FDA-approved labeling. There are potential serious ...

announced today that its advanced acne scar treatment using Focal Point Technology™ has received clearance from the U.S. Food and Drug Administration (FDA). This clinical indication affirms the ...

"FDA has become aware of reports of adverse events involving compounded topical finasteride products potentially putting consumers at risk," the April 22 statement said. "Currently, there is no ...

This week, the FDA categorized the recall as a “Class II,” meaning the use of the recalled product “may cause temporary or medically reversible adverse health consequences,” even if “the ...